ENYO Pharma Announces Two Vonafexor Data Presentations at AASLD The Liver Meeting

Lyon, France. November 3rd, 2021 – ENYO Pharma (ENYO), a private clinical stage biotechnology company developing innovative drug candidates, today announced that two abstracts on Vonafexor were accepted one as oral presentation and one as poster during the upcoming The Liver Meeting® 2021, organized by the American Association for the Study of Liver Diseases (AASLD) on November 12-15, 2021.

Download full press release (PDF)

Read next in 'Press releases'